Little Green Pharma Ltd (ASX:LGP)
Australia · Delayed Price · Currency is AUD 0.0700
-0.0020 (-2.78%)
Aug 21, 2026, 1:14 PM AEST
Little Green Pharma Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Cash & Equivalents | 7.31 | 6.96 | 14.44 |
Short-Term Investments | 5.2 | 5 | - |
Cash & Short-Term Investments | 12.51 | 11.96 | 14.44 |
Cash Growth | 4.65% | -17.22% | - |
Accounts Receivable | 6.93 | 6.79 | 5.24 |
Other Receivables | 0.65 | 0.24 | 0.24 |
Receivables | 7.58 | 7.03 | 5.49 |
Inventory | 11.1 | 15.5 | 34.22 |
Prepaid Expenses | 2.28 | 3.66 | 5.99 |
Other Current Assets | 1.19 | 0.13 | 0.56 |
Total Current Assets | 36.71 | 38.79 | 60.7 |
Property, Plant & Equipment | 16.61 | 22.23 | 22.48 |
Long-Term Investments | - | 0.24 | - |
Goodwill | 2.94 | - | - |
Other Intangible Assets | 5.57 | 1.75 | 1.23 |
Other Long-Term Assets | -0 | 0 | - |
Total Assets | 61.83 | 63 | 84.41 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Accounts Payable | 1.64 | 5.62 | 11.7 |
Accrued Expenses | 3.2 | 1.41 | 0.65 |
Short-Term Debt | 2.68 | - | - |
Current Portion of Long-Term Debt | - | 2.91 | 0.28 |
Current Portion of Leases | 0.23 | 0.66 | 0.86 |
Current Income Taxes Payable | - | 0.75 | 5.89 |
Other Current Liabilities | 1.88 | 2.76 | 1.52 |
Total Current Liabilities | 9.63 | 14.1 | 22.14 |
Long-Term Debt | - | - | 2.79 |
Long-Term Leases | 0.21 | 0.86 | 0.42 |
Other Long-Term Liabilities | 0.28 | 0.63 | 0.26 |
Total Liabilities | 10.12 | 15.58 | 25.6 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Common Stock | 48.05 | 43.32 | 42.96 |
Retained Earnings | 3.34 | 4.05 | 15.82 |
Comprehensive Income & Other | 0.32 | 0.06 | 0.03 |
Shareholders' Equity | 51.71 | 47.42 | 58.8 |
Total Liabilities & Equity | 61.83 | 63 | 84.41 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Total Debt | 3.12 | 4.43 | 4.35 |
Net Cash (Debt) | 9.39 | 7.53 | 10.09 |
Net Cash Growth | 24.73% | -25.38% | - |
Net Cash Per Share | 0.03 | 0.03 | - |
Filing Date Shares Outstanding | 273.89 | 254.94 | - |
Total Common Shares Outstanding | 273.89 | 254.94 | - |
Working Capital | 27.08 | 24.69 | 38.56 |
Book Value Per Share | 0.19 | 0.19 | - |
Tangible Book Value | 43.2 | 45.68 | 57.57 |
Tangible Book Value Per Share | 0.16 | 0.18 | - |
Land | 3.92 | 3.13 | 2.32 |
Machinery | 9.97 | 10.85 | 11.79 |
Construction In Progress | 7.69 | 9 | 8.15 |
Leasehold Improvements | 3.27 | 4.58 | 4.26 |